Skip to content

Capital Bancorp

US · CBNK #3593 by market cap Listed 2018
38.89 -0.70 -1.77%
Live - 5344 symbols - heartbeat 234s ago · 2026-10-07 19:54
After-hours 38.89 0.00%
Market cap
633.75M
P/B
1.50
EPS
3.41
Reader sentiment Are you bullish or bearish on CBNK?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
24.69 fair value ≈ 32.01 39.32
  • Implied fair-value range of 24.69-39.32, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +21.5% above the average-multiple fair value of 32.01.

Valuation each multiple against its own 5-year range

P/B ratio 1.50 In line with history 66th percentile
5-year average 1.39 · #284 of 354 in Banks - Regional
P/E ratio 11.40 Expensive vs history 81st percentile
5-year average 9.39 · forward 10.44 · #118 of 305 in Banks - Regional
P/S ratio 2.55 Expensive vs history 86th percentile
5-year average 2.05 · forward 2.24 · #79 of 354 in Banks - Regional

Vs. peers Banks - Regional

Company Market cap P/E (TTM) P/B Div yield
Capital Bancorp (CBNK) 633.75M 11.40 1.50 1.23%
Mizuho Financial (MFG) 131.05B 16.93 1.83 1.62%
HDFC Bank (HDB) 113.60B 15.61 1.35 1.60%
Itau Unibanco (ITUB) 107.35B 11.64 2.47 6.15%
ICICI Bank (IBN) 100.00B 18.03 2.66 0.83%
U.S. Bancorp (USB) 87.52B 11.21 1.44 3.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value41.84 Economic moatNone UncertaintyHigh

Trading 7.6% below Morningstar's fair value estimate.

Fair value

Capital Bancorp Inc receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 7% discount to our quantitative fair value estimate of $41.84 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The firm's profitability increases our estimated valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 8.8%, which ranks in the top 30% globally. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are undervalued.

The company's solid growth is an additional encouraging factor. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. The firm's revenue 3-year growth of 15.4%, for example, falls in the top 30% compared with global peers. Robust trailing three-year revenue growth portends a favorable future trajectory, which further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.

By Quantitative Equity Report

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.